CooperVision Satellite Meeting and Insights into MiSight® 1 Day and Myopia Control
December 20, 2024
At a CooperVision satellite meeting event, the spotlight was on MiSight® 1 Day—the first FDA-approved soft contact lens clinically proven to slow myopia progression in children aged 8-12. Join us as we bring you exclusive insights from global myopia experts on the company’s special session at the symposium: “CooperVision Satellite Meeting for Myopia Management Training and Education”.
In this session, Dr. Maria Liu shared the efficacy of MiSight 1 Day in managing pediatric myopia, backed by real-world results and the advanced technology powering its myopia control design.
![[CooperVision] Satellite meeting highlight video thumbnail CooperVision at APMMS 2024 Insights into MiSight® 1 Day and Myopia Control 2 (1) (1) (1)](https://cookiemagazine.org/wp-content/uploads/sites/6/2024/12/CooperVision-Satellite-meeting-highlight-video-thumbnail-CooperVision-at-APMMS-2024-Insights-into-MiSight®-1-Day-and-Myopia-Control-2-1-1-1.png)
